View in EDS

Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience.

Saved in:

Bibliographic Details
Title:	Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience.
Authors:	Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. ejabbour@mdanderson.org., Castagnetti F; Institute of Hematology 'Seràgnoli', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Bardey-Kanaan M; Incyte Biosciences International Sàrl, Morges, Switzerland., Soichez R; Incyte Biosciences International Sàrl, Morges, Switzerland., Nguyen NT; Incyte Biosciences International Sàrl, Morges, Switzerland., Kelly D; Incyte Corporation, Wilmington, DE, USA., Rizzo F; Incyte Biosciences International Sàrl, Morges, Switzerland., Patos P; Incyte Biosciences International Sàrl, Morges, Switzerland., García-Gutiérrez V; Departamento de Hematología y Hemoterapia, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.; Universidad de Alcalá, Madrid, Spain.
Source:	Drug safety [Drug Saf] 2026 Jul 18. Date of Electronic Publication: 2026 Jul 18.
Publication Type:	Journal Article
Journal Info:	Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1179-1942
DOI:	10.1007/s40264-026-01695-1